Home

Sapna Srivastava

CIK 1569226 · last filed 2026-07-15

Sapna Srivastava is a corporate insider who has filed 34 SEC Form 4 insider transactions across 8 companies since 2015. The most recent filing, for NUVL, was dated Jul 15, 2026. Current disclosed insider exposure totals $1.3M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.33M

Companies

8

Total Filings

34

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
NUVL Director 0 $123.96 $0 $0 7 2026-07-15
ALMS Director 3,553 $26.96 $95.8K $0 3 2026-07-02
AURA Director 38,500 $7.05 $271.6K $0 6 2026-06-15
Tourmaline Bio, Inc. (TRML) Delisted Director 0 $47.98 $0 $0 3 2025-10-28
INVA Director 44,096 $21.86 $963.9K $0 2 2024-06-20
SQZ Biotechnologies Co (SQZ) Delisted Director — $0.43 — $0 4 2023-06-15
Tourmaline Bio, Inc. (TALS) Delisted Director — $27.20 — $0 2 2023-06-14
MedAvail Holdings, Inc. (MYOS) Delisted Director — — — $0 1 2015-01-12

Recent Filings

34 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-07-15 NUVL Mixed −8,590 -$638.1K EDGAR
2026-07-02 ALMS Grant (A) +3,553 $0 EDGAR
2026-06-18 NUVL Grant (A) +3,444 $0 EDGAR
2026-06-15 AURA Grant (A) +15,000 $0 EDGAR
2025-10-28 Tourmaline Bio, Inc. (TRML) Delisted Mixed −518 $0 EDGAR
2025-08-01 ALMS Grant (A) — $0 EDGAR
2025-06-20 NUVL Grant (A) +2,647 $0 EDGAR
2025-06-18 AURA Grant (A) +13,000 $0 EDGAR
2025-06-06 Tourmaline Bio, Inc. (TRML) Delisted Grant (A) — $0 EDGAR
2024-07-01 ALMS Mixed — $0 EDGAR
Showing 1–10 of 34
Page 1 of 4
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.